Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2014, 23(6):405-409

Troponins and heart failure

Murín J, Pernický M
I. interná klinika LFUK a UNB, nemocnica Staré mesto, Bratislava, Slovenská republika

Heart failure is a chronic disease. Important here is the monitoring of serum levels of troponins (gold standard of acute myocardial infarction diagnostics). During the course of heart failure troponin serum level can also be increased, usually if hs (high sensitivity) troponin is used. Then a heart failure patient usually has a worse prognosis. We deal here with acute and chronic forms of heart failure, with a focus on troponin serum levels. We discuss causes of increased troponin serum levels, cardiac and non-cardiac. In clinical practice we put troponin serum levels into context with a clinical picture of heart failure. We look for possible causes of serum troponin increase and try to influence them with treatment.

Keywords: heart failure; hs troponins; chronic diseases (With PowerPoint presentation)

Published: June 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Murín J, Pernický M. Troponins and heart failure. Cardiology Letters. 2014;23(6):405-409.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kociol RD, Pang PS, Gheorghiade M, et al. Troponin elevation in heart failure: prevalence, mechanisms, and clinical implications. J Am Coll Cardiol 2010;56:1071-1078. Go to original source...
    2. deFilippi CR, de Lemos JA, Christenson RH, et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010;304:2494-2502. Go to original source...
    3. Masson S, Anand I, Favero C, et al. Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from two large randomized clinical trials. Circulation 2012;125:280-288. Go to original source...
    4. Tsutamoto T, Kawahara C, Nishiyama K, et al. Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure. Am Heart 2011;159:63-67. Go to original source...
    5. Xue Y, Clopton P, Peacock WF, et al. Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure. Eur J Heart Fail 2011;13:37-42. Go to original source...
    6. Pascual-Figal DA, Manzano-Fernandez S, Boronat M, et al. Soluble ST2, high-sensitivity troponin T - and N-terminal pro - B-type natriuretic peptide:complementary role for risk stratification in acutely decompensated heart failure. Eur J Heart Fail 2011;13:718-725. Go to original source...
    7. Nieminen MS, Brutsaert D, Dickstein K, et al. Euro-Heart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 2006;27:27252736. Go to original source...
    8. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J 2007;28:2525-2538. Go to original source...
    9. Thygesen K, Mair J, Katus H, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 2010;31:2197-2204. Go to original source...
    10. Sakhuja R, Green S, Oestreicher EM, et al. Amino-terminal pro-brain natriuretic peptide, brain natriuretic peptide, and troponin T for prediction of mortality in acute heart failure. Clin Chem 2007;53:412-420. Go to original source...
    11. Horwich TB, Patel J, MacLellan WR, et al. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003;108:833-838. Go to original source...
    12. Hudson MP, O'Connor CM, Gattis WA, et al. Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis. Am Heart J 2004;147:546552. Go to original source...
    13. Latini R, Masson S, Anand IS, et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007;116:1242-1249. Go to original source...
    14. Miler WL, Hartman KA, Burritt MF, et al. Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure. J Am Coll Cardiol 2009;54:1715-1721. Go to original source...
    15. Miler WL, Hartman KA, Burritt MF, et al. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation 2007;116:249257. Go to original source...
    16. Missov E, Mair J. A novel biochemical approach to congestive heart failure: cardiac troponin T. Am Heart J 1999;138(1 Pt):95-99. Go to original source...
    17. Perna ER, Macin SM, Canella JP, et al. Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification. Circulation 2004;110-2376-2382. Go to original source...
    18. Sato Y, Yamada T, Taniguchi R, et al. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 2001;103:369-374. Go to original source...
    19. Setsuta K, Seino Y, Takahshi N, et al. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol 1999;84:608-611 (A609). Go to original source...
    20. Katz SD, Hryniewicz K, Hriljac I, et al. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 2005;111:310-314. Go to original source...
    21. Sabatine MS, Morrow DA, de Lemos JA, et al. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur Heart J 2009;30:162-169. Go to original source...
    22. Turer AT, Addo TA, Martin JL, et al. Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study. J Am Coll Cardiol 2011;57:2398-2405. Go to original source...
    23. van den Bos EJ, Constantinescu AA, van Domburg RT, et al. Minor elevations in troponin I are associated with mortality and adverse cardiac events in patients with atrial fibrillation. Eur Heart J 2011;32:611-617. Go to original source...
    24. Shah RV, Chen-Tournoux AA, Picard MH, et al. Association between troponin T and impaired left ventricular relaxation in patients with acute decompensated heart failure with preserved systolic function. Eur J Echocardiogr 2009;10:765-768. Go to original source...
    25. Canty JM, Lee TC. Troponin I proteolysis and myocardial stunning: now you see it-now you dont. J Mol Cell Cardiol 2002;34:37537. Go to original source...
    26. Feng J, Schaus BJ, Fallavollita JA, et al. Preload induces troponin I degradation independently of myocardial ischemia. Circulation 2001;103:2035-2037. Go to original source...
    27. Shih H, Lee B, Lee RJ, et al. The aging heart and post-infarction left ventricular remodeling. J Am Coll Cardiol 2011;57:9-17. Go to original source...
    28. Dispenzieri A, Kyle RA, Gertz MA, et al. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet 2003;361:1787-1789. Go to original source...
    29. Sawaya H, Sebag IA, Plana JC, et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol 2011;107:1375-1380. Go to original source...
    30. Smith SC, Ladenson JH, Mason JW, et al. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 1997;95:163-168. Go to original source...
    31. Sharkey SW, Lesser JR, Menon M, et al. Spectrum and significance of electrocardiographic patterns, troponin levels, and thrombolysis in myocardial infarction frame count in patients with stress (tako-tsubo) cardiomyopathyand comparison to those in patients with ST-elevation anterior wall myocardial infarction. Am J Cardiol 2008;101:1723-1728. Go to original source...
    32. Dec GW Jr, Waldman H, Southern J, et al. Viral myocarditis mimicking acute myocardial infarction. J Am Coll Cardiol 1992;20:85-89. Go to original source...
    33. Pettersson K, Eriksson S, Wittfooth S, et al. Autoantibodies to cardiac troponin associate with higher initial concentrations and longer release of troponin I in acute coronary syndrome patients. Clin Chem 2009;55:938-945. Go to original source...
    34. Jaffe AS, Vasile VC, Milone M, et al. Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac toponin T. J Am Coll Cardiol 2011;58:1819-1824. Go to original source...
    35. de Filippi C, Wasserman S, Rosanio S, et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 2003;290:353-359. Go to original source...
    36. Aviles RJ, Askari AT, Lindahi B, et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med 2002;346:2047-2052. Go to original source...
    37. Saunders JT, Nambi V, de Lemos JA, et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the atherosclerosis risk in communities study. Circulation 2011;123:1367-1376. Go to original source...
    38. Sundstrom J, Ingelsson E, Berglund L, et al. Cardiac troponin I and risk of heart failure: a community-based cohort study. Eur Heart J 2009;30:773-781 Go to original source...
    39. Omland T, de Lemos JA, Sabatine MS, et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009;361:2538-2547. Go to original source...
    40. Eggers KM, Lagerqvist B, Oldgren J, et al. Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome. Am Heart J 2008;156:588-594. Go to original source...
    41. Eggers KM, Lagerqvist B, Venge P, et al. Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality. Circulation 2007;116:1907-1914. Go to original source...
    42. Eggers KM, Lind L, Ahlstrom, et al. Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. Eur Heart J 2008;29:2252-2258. Go to original source...
    43. Peacock WF, De Marco T, Fonarow GC, et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008;358:21172126. Go to original source...
    44. Filippatos GS, Ahmed MI, Gladden JD, et al. Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data. Eur Heart J 2011;32:712-720. Go to original source...
    45. Jankowska EA, Rozentryt P, Witkowka A, et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 2010;31:1872-1880. Go to original source...
    46. Maisel A, Mueller C, Nowak R, et al. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 2010;55:2062-2076. Go to original source...
    47. Maisel A, Mueller C, Nowak RM, et al. Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 2011;58:1057-1067. Go to original source...
    48. Mueller M, Biener M, Vafaie M, et al. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem 2012;58:209-218. Go to original source...
    49. Reichlin T, Irfan A, Twerenbold R, et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 2011;124:136-145. Go to original source...
    50. Keller T, Zeller T, Ojeda F, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011;306:2684-2693. Go to original source...
    51. Peacock WF, Emerman CE, Doleh M, et al. Retrospective review: the incidence of non-ST segment elevation MI in emergency department patients presenting with decompensated heart failure. Congest Heart Fail 2003;9:303-308. PowerPointovú prezentáciu k publikácii obsahuje on-line verzia tohto článku (www.cardiology.sk). Go to original source...

    Return to the content